The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting

Diabetic Medicine

Volumn 27, Issue 8, 2010, Pages 887-895

  Gray, L J ^a   Taub, N A ^a   Khunti, K ^a   Gardiner, E ^a   Hiles, S ^b   Webb, D R ^a   Srinivasan, B T ^a   Davies, M J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

prevention; risk score; screening; type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; DIABETIC PATIENT; ETHNICITY; EUROPE; FEMALE; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LEICESTER RISK ASSESSMENT SCORE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SOUTH ASIA; UNITED KINGDOM; VALIDATION PROCESS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 77954791260     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03037.x     Document Type: Article

References (32)

1. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet Med 1998 15 : 539 553.
2. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies Arch Intern Med 2004 164 : 2147 2155.
3. World Health Organization. Fact sheet no. 312, Diabetes.
4. Rathmann W, Haastert B, Icks A, Lawel H, Meisinger C, Holle R et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003 46 : 182 189.
5. Webb DR, Khunti K, Srinivasan B, Gray L, Jarvis J, Hiles S et al. ADDITION Leicester: prevalence of impaired glucose regulation (IGR) and screen detected Type 2 diabetes (T2D) in a mixed ethnic UK population. Diabet Med 2009 26 (Suppl 1 3.
6. Norris SL, Kansagara D, Bougatsos C, Fu R. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventative Services Task Force. Ann Intern Med 2008 148 : 855 868.
7. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998 317 : 703 713.
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
9. Spijkerman AMW, Henry RMA, Dekker JM, Nijpels G, Kostense PJ, Kors JA et al. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. J Intern Med 2004 256 : 429 436.
10. Spijkerman AMW, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice. Diabetes Care 2003 26 : 2604 2608.
11. Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002 359 : 2072 2077.
12. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 : 393 403.
13. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 344 : 1343 1350. (Pubitemid 32378388)
14. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008 336 : 1180 1185.
15. Goyder E, Wild S, Fischbacher C, Carlisle J, Peters J. Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Fam.Pract 2008 25 : 370 375.
16. Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diabetes Care 2004 27 : 367 371.
17. UK National Screening Committee. The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management. 2008. Document Number: Vascular 03/2008.
18. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice. Diabetes Metab Res Rev 2000 16 : 164 171.
19. Lindström J, Tuomilehto J. The Diabetes Risk Score: a practical tool to predict diabetes risk. Diabetes Care 2003 26 : 725 731.
20. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997 20 : 491 496.
21. Webb D, Khunti K, Srinivasan B, Gray L, Taub N, Campbell S et al. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 2010 19 : 16.
22. NICE. Obesity Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. 2006. Document Number: Clinical guidelines CG43.
23. Riste L, Khan F, Cruickshank K. High prevalence of Type 2 Diabetes in all ethnic groups, including Europeans in a British Inner City. Diabetes Care 2001 24 : 1377 1383.
24. Forouhi N, Merrick D, Goyder E, Ferguson B, Abbas J, Lachowycz K et al. Diabetes prevalence in England, 2001 - estimates from an epidemiological model. Diabet Med 2006 23 : 189 197.
25. Davies MJ, Tringham JR, Farooqi AM, Jarvis J, Raymond N, Skinner TC et al. STAR: screening those at risk: study design and recruitment. Diabet Med 2003 20 (Suppl 2 68.
26. Tringham J. Strategies for the early detection of type 2 diabetes in an at risk population Dissertation/Thesis University of Leicester, 2006.
27. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007 334 : 299.
28. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006 368 : 1673 1679.
29. Schwarz PE, Schwarz J, Schuppenies A, Bornstein S, Schulze J. Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007 122 : 258 263.
30. Glümer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006 29 : 410 414.
31. Wen CP, David Cheng TY, Tsai SP, Chan HT, Hsu HL, Hsu CC et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians Public health nutrition. 2009 12 : 497 506.
32. Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S. Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 2005 70 : 63 70.